The Effects of Erythromycin in Patients Treated with Cyclosporine
Authors:
- 1 May 1986
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 104 (5) , 660-661
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent OnsetScience, 1984
- Effect of erythromycin on carbamazepine kineticsClinical Pharmacology & Therapeutics, 1983
- Depression of theophylline elimination by erythromycinClinical Pharmacology & Therapeutics, 1981
- Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.The Journal of Pharmacology and Experimental Therapeutics, 1981
- IMMUNOLOGICAL AND PHARMACOLOGICAL MONITORING IN THE CLINICAL USE OF CYCLOSPORIN AThe Lancet, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Selective effects of cyclosporin A on functional B cell subsets in the mouse.The Journal of Immunology, 1980
- Demethylation of erythromycins by rabbit tissues in vitroBiochemical Pharmacology, 1965